![]() |
市场调查报告书
商品编码
1897309
兽医免疫诊断市场规模、份额和成长分析(按产品类型、技术、动物种类、疾病种类、最终用户和地区划分)-2026-2033年产业预测Veterinary Immunodiagnostics Market Size, Share, and Growth Analysis, By Product, By Technology, By Animal Type, By Disease Type, By End User, By Region - Industry Forecast 2026-2033 |
||||||
全球兽医免疫诊断市场规模预计在 2024 年达到 29.2 亿美元,从 2025 年的 31.6 亿美元增长到 2033 年的 58.9 亿美元,在预测期(2026-2033 年)内复合年增长率为 8.1%。
全球兽医免疫诊断市场预计将因动物疾病的日益增加、专业免疫诊断检测的普及以及技术的进步而成长。宠物饲养量的快速增长和对动物性食品需求的不断增加也进一步推动了市场扩张。新兴经济体蕴藏着巨大的成长潜力,但由于这些地区兽医诊断基础设施的匮乏,也面临许多挑战。此外,全球疫情引发的检测需求激增,促使业界相关人员和实验室开发新的动物检测解决方案。儘管主要卫生组织不建议对动物进行常规的新冠病毒检测,但随着公共卫生情况的变化,是否进行检测的决定可能会随之而来,并可能需要兽医和卫生部门的共同决策。
推动全球兽医免疫诊断市场发展的因素
全球兽医免疫诊断市场的主要驱动力是应对通用病的迫切需求,这些感染疾病可从动物传播给人类。由于许多病原体来自家畜和通用动物(如犬猫),因此疾病传播的可能性很高。狂犬病、钩端螺旋体病和胃肠道疾病等主要感染疾病凸显了兽医学领域对有效诊断解决方案的需求。随着人们对这些健康风险的认识不断提高,对先进免疫诊断工具的需求日益迫切,以确保公众和动物健康,最终推动兽医诊断市场的成长和创新。
全球兽医免疫诊断市场阻碍因素
宠物照护成本的不断上涨是全球兽医免疫诊断市场发展面临的一大阻碍因素。兽医医疗费用已成为宠物护理行业最大的支出项目之一,给宠物饲主带来了沉重的财务负担。先进诊疗计画的价格涨幅惊人,往往高达数千至数万美元。此外,即使是常规的兽医服务也可能需要花费数百至数千美元。这些日益增长的经济压力可能会阻碍宠物饲主获得必要的诊断服务,最终影响该市场的整体需求。
全球兽医免疫诊断市场趋势
受环境变化和社会经济因素的影响,感染疾病和媒介传播疾病的发生率不断上升,推动了全球兽医免疫诊断市场显着增长。已开发地区宠物主人数量的增加以及伴侣动物照护日益受到重视,促使市场对快速、准确的诊断工具的需求激增。此外,RT-PCR等先进技术的日益普及也进一步强化了这一趋势,这些技术比传统方法更有效率、更准确。有效疾病控制策略的需求凸显了兽医免疫诊断的关键作用,预计该市场将持续成长,以应对不断变化的动物健康挑战。
Global Veterinary Immunodiagnostics Market size was valued at USD 2.92 Billion in 2024 and is poised to grow from USD 3.16 Billion in 2025 to USD 5.89 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).
The global veterinary immunodiagnostics market is poised for growth driven by the increasing prevalence of animal diseases, enhanced access to specialized immunodiagnostic tests, and advancements in technology. The surge in pet ownership and demand for animal-derived food products further bolster market expansion. Emerging economies present promising opportunities for growth; however, the market faces challenges stemming from inadequate veterinary diagnostic infrastructure in these regions. Additionally, the heightened focus on testing due to the global pandemic has spurred the development of novel animal testing solutions by industry players and laboratories. While major health organizations do not endorse routine COVID-19 testing in animals, decisions regarding testing may arise from evolving public health circumstances, necessitating collective judgments by veterinarians and health officials.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Veterinary Immunodiagnostics Market Segments Analysis
Global Veterinary Immunodiagnostics Market is segmented by Product, Technology, Animal Type, Disease Type, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Immunodiagnostics and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals and Livestock. Based on Disease Type, the market is segmented into Infectious Disease, Endocrinology, Oncology, Cardiology and Others. Based on End User, the market is segmented into Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-care/ In-house Testing and Veterinary Research Institutes & Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Veterinary Immunodiagnostics Market
The Global Veterinary Immunodiagnostics market is significantly driven by the pressing need to address serious zoonotic illnesses that can be transmitted from animals to humans. With numerous pathogens originating from livestock and companion animals, such as dogs and cats, the potential for disease transmission is high. Notable zoonotic infections, including rabies, leptospirosis, and gastrointestinal diseases, highlight the necessity for effective diagnostic solutions in veterinary medicine. As awareness of these health risks grows, the demand for advanced immunodiagnostic tools becomes increasingly vital to ensure public and animal health, ultimately propelling market growth and innovation in veterinary diagnostics.
Restraints in the Global Veterinary Immunodiagnostics Market
The rising expenses associated with pet care are a notable restraint in the Global Veterinary Immunodiagnostics market. Veterinary care has become one of the largest cost categories within the pet care industry, reflecting a significant financial burden for pet owners. The increasing prices of high-end procedures can be staggering, often ranging from thousands to tens of thousands of dollars. Additionally, even routine veterinary services can lead to considerable expenditures, ranging from a few hundred to several thousand dollars. This growing financial pressure may deter pet owners from seeking necessary diagnostic services, ultimately impacting the overall demand in this market.
Market Trends of the Global Veterinary Immunodiagnostics Market
The Global Veterinary Immunodiagnostics market is witnessing significant growth driven by the increasing prevalence of zoonotic and vector-borne diseases, influenced by environmental changes and socio-economic factors. As pet ownership rises and companion animal healthcare gains prominence in developed regions, the demand for rapid and precise diagnostic tools intensifies. This trend is further bolstered by a heightened preference for advanced technologies such as RT-PCR, surpassing traditional methods in both efficiency and accuracy. The need for effective disease management strategies highlights the pivotal role of veterinary immunodiagnostics, positioning the market for sustained expansion in response to evolving health challenges in animals.